st-Ht31 P is a synthetic peptide designed to disrupt anchoring interactions between proteins and A-kinase anchoring proteins. The sequence incorporates helical tendencies that enable competition with endogenous binding motifs. Researchers use it to study compartmentalization and regulatory protein complexes. Its defined structure supports mechanistic dissection of scaffold interactions.
st-Ht31 P is a synthetic peptide derivative widely utilized in molecular and cellular biology for its ability to modulate protein-protein interactions involving A-kinase anchoring proteins (AKAPs) and the regulatory subunits of protein kinase A (PKA). As a cell-permeable peptide, it is engineered to competitively inhibit the binding of AKAPs to PKA, thereby disrupting the spatial localization and compartmentalization of PKA signaling within cells. This unique property makes st-Ht31 P an indispensable research tool for studying the dynamics of cAMP-dependent signaling pathways and the physiological roles of AKAP-PKA interactions in various cellular processes. Its structural modification, often including a proline residue to enhance stability or specificity, further supports its application in advanced biochemical and pharmacological investigations.
Signal transduction research: One of the principal applications of st-Ht31 P is in the dissection of cAMP/PKA signaling pathways. By selectively disrupting the interaction between AKAPs and the regulatory subunits of PKA, the peptide enables researchers to investigate how spatially confined PKA activity influences downstream signaling events. This approach provides mechanistic insights into the regulation of phosphorylation cascades, gene expression, and cellular responses to extracellular stimuli, allowing for a more nuanced understanding of compartmentalized signal transduction.
Cellular localization studies: The ability of st-Ht31 P to interfere with AKAP-mediated anchoring of PKA is instrumental for elucidating the functional consequences of PKA mislocalization. Researchers employ this peptide to examine how the redistribution of PKA within the cell affects processes such as cytoskeletal dynamics, vesicle trafficking, and local substrate phosphorylation. Such studies are crucial for unraveling the spatial organization of signaling networks and for identifying subcellular domains critical for specific PKA-dependent functions.
Protein-protein interaction assays: The peptide serves as a valuable competitor in assays designed to characterize AKAP-PKA interactions. By introducing st-Ht31 P into in vitro or cell-based systems, investigators can quantitatively assess the affinity and specificity of AKAP binding motifs, as well as screen for novel protein partners involved in PKA anchoring. This application supports the identification of new regulatory proteins and the mapping of interaction domains, advancing the understanding of PKA signaling complexes.
Functional analysis of AKAP isoforms: Utilizing st-Ht31 P in comparative studies of different AKAP isoforms allows for the delineation of isoform-specific roles in cellular signaling. By selectively disrupting AKAP-PKA interactions, researchers can determine the contribution of individual anchoring proteins to physiological processes such as synaptic plasticity, cardiac contractility, or hormone secretion. This targeted approach aids in distinguishing redundant versus unique functions among the diverse AKAP family members.
Peptide-based inhibitor development: The structural features and mechanistic action of st-Ht31 P provide a template for the rational design of novel peptide-based inhibitors targeting protein-protein interactions. Its use in structure-activity relationship studies facilitates the optimization of peptide sequences for improved specificity, stability, or cell permeability. These insights are valuable for advancing chemical biology approaches aimed at modulating intracellular signaling pathways, as well as for developing new molecular tools for dissecting complex cellular processes.
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More